Published July 18, 2023 | Version v1

Search strategies for generic justification of 18F-PSMA PET/CT in the staging of primary prostate cancer and the restaging of recurrent and metastatic prostate cancer

Authors/Creators

  • 1. Health Information and Quality Authority

Description

The dataset includes the complete, reproducible search strategies for all literature databases searched during this project. The search strategies address the following research questions:

RQ 1: In the primary staging of patients with high risk prostate cancer, what is the sensitivity, specificity and diagnostic accuracy of 18F-PSMA?

RQ 2: In patients with biochemically recurrrent prostate cancer, what is the sensitivity, specificity and diagnostic accuracy of 18F-PSMA?

RQ 3: What is the risk of adverse events (including dose) associated with receiving 18F-PSMA?

RQ 4: Is 18F-PSMA uptake associated with response to treatments for metastatic prostate cancer?

Files

Search Strategies_2023_03_zenodo.pdf

Files (429.6 kB)

Name Size Download all
md5:f4e3745cb7b87f8fd6ad65eb481badfb
429.6 kB Preview Download